Waiting List — No Shares Offered Here
Tachyra is preparing a limited private round to fund physician outreach for our AI clinical decision support Beta. This is a waiting list for accredited investors who want first look when the formal offering opens.
25-Medication Cross-Check
Cross-references up to 25 concurrent medications — active and inactive ingredients alike — against a patient’s medication history and flagged conditions in a single pass.
Differential Diagnosis Support
Surfaces the full range of plausible explanations for a patient’s presentation, for physician review — never an autonomous diagnosis.
Unified Records Import
Imports and unifies labs, imaging reports, and other clinical records already on file into a single patient view.
Planned offering capacity CAPPED — LIMITED SIZE
Best terms — limited availability
Founding Investor Tranche
First $750,000
$8.0M
Valuation cap
20%
Discount
Standard Tranche
Remaining to $6,000,000
$12.0M
Valuation cap
15%
Discount